financetom
Business
financetom
/
Business
/
MannKind's Q1 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MannKind's Q1 Adjusted Earnings, Revenue Increase
May 26, 2025 4:12 AM

09:33 AM EDT, 05/08/2025 (MT Newswires) -- MannKind ( MNKD ) reported Q1 adjusted earnings Thursday of $0.07 per share, up from $0.06 a year earlier.

An analyst polled by FactSet expected $0.06.

Revenue for the quarter ended March 31 was $78.4 million, compared with $66.3 million a year earlier.

Analysts polled by FactSet expected $76 million.

Price: 4.61, Change: -0.24, Percent Change: -4.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Hyliion Shares Friday?
What's Going On With Hyliion Shares Friday?
Sep 27, 2024
Hyliion Holdings Corp. ( HYLN ) stock is trading higher Friday after the company announced its KARNO linear generator is now an eligible technology under California’s Renewables Portfolio Standard (RPS). The Details: The qualification of Hyliion’s KARNO linear generator as an eligible technology enables the company to play a larger role in achieving California’s climate goals. California’s RPS requires 60%...
HubSpot Q3 Results Seen Matching Expectations, Boosting Q4 Prospects, Oppenheimer Says
HubSpot Q3 Results Seen Matching Expectations, Boosting Q4 Prospects, Oppenheimer Says
Sep 27, 2024
03:26 PM EDT, 09/27/2024 (MT Newswires) -- HubSpot's ( HUBS ) customer activity picked up in the summer, and the Q3 performance was seen in line with the internal outlook, boosting prospects for the Q4 pipeline, Oppenheimer said Friday in a report, citing a top partner of the software company. HubSpot ( HUBS ) may add 9,000 to 10,000 customers,...
AbbVie Submits Biologics License Application for Lung Cancer Drug
AbbVie Submits Biologics License Application for Lung Cancer Drug
Sep 27, 2024
01:13 PM EDT, 09/27/2024 (MT Newswires) -- AbbVie ( ABBV ) submitted a biologics license application to the US Food and Drug Administration for accelerated approval of telisotuzumab vedotin to treat adult patients with previously treated, locally advanced or metastatic non-small cell lung cancer. The submission is based on data from a phase 2 trial, the company said Friday in...
Argentina's Milei plans to privatize state airline by decree
Argentina's Milei plans to privatize state airline by decree
Sep 27, 2024
(Reuters) - Argentina's President Javier Milei intends to sign a decree next week aimed at the privatization of flag carrier Aerolineas Argentinas, said presidential spokesman Manuel Adorni. WHY IT'S IMPORTANT Milei says the current structure of Argentina's largest airline is bloated and is costing the country too much. His efforts to trim costs have prompted fierce protests by unions. KEY...
Copyright 2023-2026 - www.financetom.com All Rights Reserved